3 years ago
MRNA
AnalystsTyler Van BurenTyler Van Buren's Stock Forecasts
AnalystsTyler Van Buren
Analyst Ranking
Bottom 5%
#5114 out of 5342 analysts
Average Return
-9.23%
Win Rate
40%21 out of 53
Risk vs Reward
Poor
Good
Tyler Van Buren's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Biohaven LtdBHVN | +61.87% | $8.34 | $13.50 | 2025-11-05 - 2026-07-31 | Strong Buy |
Neurogene IncNGNE | +60.57% | $175.00 | $281.00 | 2020-01-10 - 2021-01-08 | Strong Buy |
Reata Pharmaceuticals IncRETA | +59.76% | $107.89 | $172.36 | 2023-07-06 - 2023-09-25 | Buy |
Travere Therapeutics IncTVTX | +58.96% | $35.16 | $55.89 | 2025-10-31 - 2026-07-31 | Strong Buy |
Gilead Sciences IncGILD | +57.70% | $65.42 | $103.17 | 2024-04-26 - 2025-04-25 | Strong Buy |
Tyler Van Buren Analyst Color
Get additional color on Tyler Van Buren's coverage of popular stocks
5 years ago
MRNA
Tyler Van Buren's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Travere Therapeutics IncTVTX | 3 | Strong Buy | $60.00 | +7.35% | Maintains | 3 months ago |
Regeneron Pharmaceuticals IncREGN | 8 | Strong Buy | $960.00 | +25.88% | Maintains | 3 months ago |
Soleno Therapeutics IncSLNO | 2 | Hold | $53.00 | -0.02% | Downgrades | 4 months ago |
Biohaven LtdBHVN | 4 | Strong Buy | $30.00 | +122.22% | Maintains | 5 months ago |
Arcutis Biotherapeutics IncARQT | 1 | Strong Buy | $35.00 | +30.31% | Maintains | 5 months ago |
Crispr Therapeutics AgCRSP | 3 | Hold | $45.00 | -6.23% | Maintains | 6 months ago |
Bridgebio Pharma IncBBIO | 1 | Strong Buy | $95.00 | +18.62% | Maintains | 9 months ago |
Gilead Sciences IncGILD | 4 | Strong Buy | $125.00 | -4.00% | Maintains | 9 months ago |
Moderna IncMRNA | 6 | Hold | $60.00 | N/A | Maintains | 2 years ago |
Reata Pharmaceuticals IncRETA | 1 | Buy | $140.00 | N/A | Initiates Coverage On | 3 years ago |
Deciphera Pharmaceuticals IncDCPH | 2 | Buy | $30.00 | N/A | Maintains | 4 years ago |
Immunocore Holdings PLCIMCR | 1 | Buy | $70.00 | N/A | Initiates Coverage On | 4 years ago |
Zentalis Pharmaceuticals IncZNTL | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Turning Point Therapeutics IncTPTX | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Fate Therapeutics IncFATE | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Arvinas IncARVN | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Tyra Biosciences IncTYRA | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Essa Pharma IncEPIX | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 5 years ago |
Gyre Therapeutics IncGYRE | 1 | Strong Buy | $225.00 | N/A | Initiates Coverage On | 5 years ago |
Gracell Biotechnologies IncGRCL | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Aligos Therapeutics IncALGS | 1 | Strong Buy | $875.00 | N/A | Initiates Coverage On | 6 years ago |
Beone Medicines LtdONC | 2 | Strong Sell | $185.00 | N/A | Downgrades | 6 years ago |
Mirati Therapeutics IncMRTX | 1 | Strong Buy | $210.00 | N/A | Maintains | 6 years ago |
Inozyme Pharma IncINZY | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 6 years ago |
Nurix Therapeutics IncNRIX | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 6 years ago |
Neurogene IncNGNE | 2 | Strong Buy | $150.00 | N/A | Maintains | 6 years ago |
Tcr2 Therapeutics IncTCRR | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 6 years ago |
Poseida Therapeutics IncPSTX | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 6 years ago |
Akouos IncAKUS | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 6 years ago |
Cypherpunk Technologies IncCYPH | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 6 years ago |
Pliant Therapeutics IncPLRX | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 6 years ago |
Harpoon Therapeutics IncHARP | 1 | Strong Buy | $350.00 | N/A | Initiates Coverage On | 6 years ago |
Gossamer Bio IncGOSS | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 6 years ago |
Theravance Biopharma IncTBPH | 1 | Strong Buy | $35.00 | N/A | Maintains | 6 years ago |
Adverum Biotechnologies IncADVM | 1 | Strong Buy | $200.00 | N/A | Reiterates | 7 years ago |
Omeros CorpOMER | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 9 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Neos Therapeutics IncNEOS | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 9 years ago |
Aerie Pharmaceuticals IncAERI | 1 | Buy | $70.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.